Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 31;10(15):3431. doi: 10.3390/jcm10153431

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Distribution (%) of different compounds by pharmacological treatment lines in PsO (a) and PsA (b) patients in the Caserta LHU during the years 2016–2018. Legend: bDMARD, Biological Disease-Modifying Anti-rheumatic Drugs; csDMARD, Conventional synthetic Disease-Modifying Anti-rheumatic Drugs; DMARD: Disease-Modifying Anti-rheumatic Drugs; MTX, methotrexate; NSAIDs, nonsteroidal anti-inflammatory drugs; PsA, psoriatic arthritis; PsO, psoriasis; tsDMARD: Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs. Note: Only PsO/PsA patients with at least 6 months post-Index continuous enrollment in their database were included in this analysis.